365 related articles for article (PubMed ID: 25386959)
1. Codeine-induced hyperalgesia and allodynia: investigating the role of glial activation.
Johnson JL; Rolan PE; Johnson ME; Bobrovskaya L; Williams DB; Johnson K; Tuke J; Hutchinson MR
Transl Psychiatry; 2014 Nov; 4(11):e482. PubMed ID: 25386959
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice.
Mika J; Wawrzczak-Bargiela A; Osikowicz M; Makuch W; Przewlocka B
Brain Behav Immun; 2009 Jan; 23(1):75-84. PubMed ID: 18684397
[TBL] [Abstract][Full Text] [Related]
3. Spinal cord glia and interleukin-1 do not appear to mediate persistent allodynia induced by intramuscular acidic saline in rats.
Ledeboer A; Mahoney JH; Milligan ED; Martin D; Maier SF; Watkins LR
J Pain; 2006 Oct; 7(10):757-67. PubMed ID: 17018336
[TBL] [Abstract][Full Text] [Related]
4. A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine.
Johnston IN; Milligan ED; Wieseler-Frank J; Frank MG; Zapata V; Campisi J; Langer S; Martin D; Green P; Fleshner M; Leinwand L; Maier SF; Watkins LR
J Neurosci; 2004 Aug; 24(33):7353-65. PubMed ID: 15317861
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin A increases analgesic effects of morphine, counters development of morphine tolerance and modulates glia activation and μ opioid receptor expression in neuropathic mice.
Vacca V; Marinelli S; Luvisetto S; Pavone F
Brain Behav Immun; 2013 Aug; 32():40-50. PubMed ID: 23402794
[TBL] [Abstract][Full Text] [Related]
6. Tolerance, opioid-induced allodynia and withdrawal associated allodynia in infant and young rats.
Zissen MH; Zhang G; McKelvy A; Propst JT; Kendig JJ; Sweitzer SM
Neuroscience; 2007 Jan; 144(1):247-62. PubMed ID: 17055659
[TBL] [Abstract][Full Text] [Related]
7. Role of Nociceptor Toll-like Receptor 4 (TLR4) in Opioid-Induced Hyperalgesia and Hyperalgesic Priming.
Araldi D; Bogen O; Green PG; Levine JD
J Neurosci; 2019 Aug; 39(33):6414-6424. PubMed ID: 31209174
[TBL] [Abstract][Full Text] [Related]
8. Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia.
Hutchinson MR; Coats BD; Lewis SS; Zhang Y; Sprunger DB; Rezvani N; Baker EM; Jekich BM; Wieseler JL; Somogyi AA; Martin D; Poole S; Judd CM; Maier SF; Watkins LR
Brain Behav Immun; 2008 Nov; 22(8):1178-89. PubMed ID: 18599265
[TBL] [Abstract][Full Text] [Related]
9. TRPV1 receptor in expression of opioid-induced hyperalgesia.
Vardanyan A; Wang R; Vanderah TW; Ossipov MH; Lai J; Porreca F; King T
J Pain; 2009 Mar; 10(3):243-52. PubMed ID: 18774343
[TBL] [Abstract][Full Text] [Related]
10. Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1beta.
Lewis SS; Hutchinson MR; Rezvani N; Loram LC; Zhang Y; Maier SF; Rice KC; Watkins LR
Neuroscience; 2010 Jan; 165(2):569-83. PubMed ID: 19833175
[TBL] [Abstract][Full Text] [Related]
11. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
[TBL] [Abstract][Full Text] [Related]
12. Opioid activation of toll-like receptor 4 contributes to drug reinforcement.
Hutchinson MR; Northcutt AL; Hiranita T; Wang X; Lewis SS; Thomas J; van Steeg K; Kopajtic TA; Loram LC; Sfregola C; Galer E; Miles NE; Bland ST; Amat J; Rozeske RR; Maslanik T; Chapman TR; Strand KA; Fleshner M; Bachtell RK; Somogyi AA; Yin H; Katz JL; Rice KC; Maier SF; Watkins LR
J Neurosci; 2012 Aug; 32(33):11187-200. PubMed ID: 22895704
[TBL] [Abstract][Full Text] [Related]
13. Comparative actions of the opioid analgesics morphine, methadone and codeine in rat models of peripheral and central neuropathic pain.
Erichsen HK; Hao JX; Xu XJ; Blackburn-Munro G
Pain; 2005 Aug; 116(3):347-358. PubMed ID: 15982817
[TBL] [Abstract][Full Text] [Related]
14. Regulation of spinal neuroimmune responses by prolonged morphine treatment in a rat model of cancer induced bone pain.
Cao F; Gao F; Xu AJ; Chen ZJ; Chen SS; Yang H; Yu HH; Mei W; Liu XJ; Xiao XP; Yang SB; Tian XB; Wang XR; Tian YK
Brain Res; 2010 Apr; 1326():162-73. PubMed ID: 20176002
[TBL] [Abstract][Full Text] [Related]
15. Persistent hyperalgesia in the cisplatin-treated mouse as defined by threshold measures, the conditioned place preference paradigm, and changes in dorsal root ganglia activated transcription factor 3: the effects of gabapentin, ketorolac, and etanercept.
Park HJ; Stokes JA; Pirie E; Skahen J; Shtaerman Y; Yaksh TL
Anesth Analg; 2013 Jan; 116(1):224-31. PubMed ID: 23223118
[TBL] [Abstract][Full Text] [Related]
16. Blockade of Toll-Like Receptors (TLR2, TLR4) Attenuates Pain and Potentiates Buprenorphine Analgesia in a Rat Neuropathic Pain Model.
Jurga AM; Rojewska E; Piotrowska A; Makuch W; Pilat D; Przewlocka B; Mika J
Neural Plast; 2016; 2016():5238730. PubMed ID: 26962463
[TBL] [Abstract][Full Text] [Related]
17. Systemic synergism between codeine and morphine in three pain models in mice.
Miranda HF; Noriega V; Zepeda RJ; Sierralta F; Prieto JC
Pharmacol Rep; 2013; 65(1):80-8. PubMed ID: 23563026
[TBL] [Abstract][Full Text] [Related]
18. Nociception increases during opioid infusion in opioid receptor triple knock-out mice.
Juni A; Klein G; Pintar JE; Kest B
Neuroscience; 2007 Jun; 147(2):439-44. PubMed ID: 17544222
[TBL] [Abstract][Full Text] [Related]
19. Possible involvement of toll-like receptor 4/myeloid differentiation factor-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequences.
Hutchinson MR; Lewis SS; Coats BD; Rezvani N; Zhang Y; Wieseler JL; Somogyi AA; Yin H; Maier SF; Rice KC; Watkins LR
Neuroscience; 2010 May; 167(3):880-93. PubMed ID: 20178837
[TBL] [Abstract][Full Text] [Related]
20. Social environment alters opioid-induced hyperalgesia and antinociceptive tolerance in adolescent mice.
Bates ML; Emery MA; Wellman PJ; Eitan S
Eur J Pain; 2016 Jul; 20(6):998-1009. PubMed ID: 26762580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
